Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02756390 · ClinicalTrials.gov registry record · NA
CBTI-CS: A Novel Cognitive-Behavioral Treatment for Insomnia in Cancer Survivors
A NA study of Insomnia, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
- 1
- Study location
NCT02756390: Completed NA study of Insomnia, sponsored by Dana-Farber Cancer Institute.
NCT02756390 is a NA study of Insomnia that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 56 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02756390, a NA study of Insomnia, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is evaluating the effectiveness of a 3-session behavioral intervention for insomnia in cancer survivors. This is a behavioral intervention study, and no medications are involved.
Primary Outcome
The ISI is a 7-item self-report questionnaire assessing severity, and impact of insomnia symptoms.
Conditions Studied
Interventions
- BEHAVIORAL Sleep Hygiene
- BEHAVIORAL CBTI-CS
- BEHAVIORAL CBTI-CS via Telehealth
Study Locations (1)
Massachusetts
- Dana Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2015-12 |
| Est. Completion | 2018-05-14 |
| Phase | NA |
What the finished NCT02756390 record still lists
NCT02756390 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (67% lower).
The record links to 1 condition, with Insomnia appearing as the primary indexed condition, and to 3 interventions - of which Sleep Hygiene is the first listed.
NCT02756390 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02756390 about?
NCT02756390 is a clinical study titled "CBTI-CS: A Novel Cognitive-Behavioral Treatment for Insomnia in Cancer Survivors". This research study is evaluating the effectiveness of a 3-session behavioral intervention for insomnia in cancer survivors. This is a behavioral intervention study, and no medications are involved.
What is the current status of trial NCT02756390?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2015-12. Estimated completion is 2018-05-14.
What conditions does trial NCT02756390 study?
This clinical trial studies the following conditions: Insomnia.
What interventions are being tested in trial NCT02756390?
The interventions under investigation include: Sleep Hygiene (BEHAVIORAL), CBTI-CS (BEHAVIORAL), CBTI-CS via Telehealth (BEHAVIORAL).
Who is sponsoring clinical trial NCT02756390?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02756390 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02756390's enrollment target sits among peer trials
56 95th of 151 higher than 54 of 151 other Insomnia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
mPATH for Low-income Older Adults
RECRUITING · NA
-
Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD
RECRUITING · NA
-
Adapted CBT-I for Adolescents With Insomnia : The DREAM-IT Study
RECRUITING · NA
-
Treatments in Women Veterans With Insomnia and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia